IP Library Assignment 036478/0611
Patent Assignment
Reel/Frame 036478/0611

Security Interest

Recorded: 2015-09-02 Pages: 6
Assignor
KADMON PHARMACEUTICALS, LLC
Executed: 2015-08-28
Assignee
MACQUARIE US TRADING LLC
225 WEST WASHINGTON STREET, 21ST FLOOR, CHICAGO, ILLINOIS, 60606
Covered Properties (3)
Process for Producing Wet Ribavirin Pellets
Patent: 6,720,000 →
Application: 09/812,024 →
Publication: US 2003/0018000
Composition Containing Ribavirin and Use Thereof
Patent: 7,538,094 →
Application: 10/882,358 →
Publication: US 2005/0019406
Large Dose Ribavirin Formulations
Patent: 7,723,310 →
Application: 11/201,311 →
Publication: US 2006/0083785
Related Assignments (7)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement Jun 25, 2013
From: KADMON PHARMACEUTICALS, LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 030678/0514 →
Security Agreement Jun 25, 2013
From: KADMON PHARMACEUTICALS, LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 030678/0620 →
Security Interest Aug 31, 2015
From: KADMON PHARMACEUTICALS, LLC
To: PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP
Reel/Frame 036460/0811 →
Release of Security Interest Aug 31, 2015
From: MACQUARIE US TRADING LLC
To: KADMON PHARMACEUTICALS, LLC
Reel/Frame 036461/0825 →
Change of Name Feb 3, 2016
From: THREE RIVERS PHARMACEUTICALS, LLC
To: KADMON PHARMACEUTICALS, LLC
Reel/Frame 037690/0466 →
Termination of Patent and Trademark Security Agreement Nov 25, 2019
From: PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP
To: KADMON PHARMACEUTICALS, LLC
Reel/Frame 051106/0789 →
Assignment of Assignor's Interest Jul 26, 2022
From: KADMON PHARMACEUTICALS, LLC
To: CHARTWELL PHARMACEUTICALS LLC
Reel/Frame 060622/0317 →